By Bernard McMahon
Its current focus is Bangladesh where BBUK has identified and established strong relationships and partnerships with decision makers in Hospitals, Universities, Government Ministries and Enterprises throughout the country. Together with their partners, there is a shared vision of developing the next generation of personalised healthcare, science based innovative services, and professionals.
A major initiative is the introduction of New Born Screening in Bangladesh for congenital hypothyroidism (CHT), which affects around 1 in 1500 babies of the more than 3.5m births each year in Bangladesh. BBUK's team is coordinating and leading this ambitious program in conjunction with Sheffield Children's Hospital, who will provide clinical guidance and training, Labsystems in Finland who are supplying the point of care devices, the Bangladesh Ministry of Health and senior clinicians in Bangladesh who are implementing the program on the ground.
NTH Executive Chairman, Bernard McMahon, is working with BBUK’s founders in the roll of interim MD to raise investment, establish systems and procedures.
Relationships created with Healthcare UK, Sheffield Children’s Hospital, the Universities of Sheffield, Bradford and Manchester, as well as established British companies, are enabling collaborations to create a portfolio of knowledge based services. Through this mutually beneficial partnership NTH is opening up the rapidly growing economy of Bangladesh to all our clients and partners.
New Technology Horizons Limited is a registered company in England and Wales
Company No. 10864778
VAT No. 273 5783 70
Registered office: 6 Broadfield Court, Broadfield Road, Sheffield S8 0XF, United Kingdom
New Technology Horizons LLC. A Texas limited liability company
Company No. 802791225
Registered office: 1800 Rogers Rd, Fort Worth, TX 76107, USA